Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue 5, 2015, Pages 599-603

  Haukoos, Jason S ^a,b,c   Hopkins, Emily ^a,b   Bucossi, Meggan M ^a,b   Lyons, Michael S ^d   Rothman, Richard E ^e   White, Douglas A E ^f,g   Al Tayyib, Alia A ^c,h   Bradley Springer, Lucy ⁱ   Campbell, Jonathan D ⁱ   Sabel, Allison L ^a,c   Thrun, Mark W ^b,h  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Food Science and Human Nutrition   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ALAMEDA COUNTY MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h DENVER PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

Author keywords

Denver HIV Risk Score; epidemiology; HIV infection; risk; screening; targeted; validation

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DENVER HIV RISK SCORE; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; FEMALE; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; UNITED STATES; VALIDATION STUDY; YOUNG ADULT; ADOLESCENT; HIV INFECTIONS; PREVALENCE; PROCEDURES; RISK ASSESSMENT;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; YOUNG ADULT;

EID: 84925273749     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000518     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention-Division of HIV/AIDS Prevention. Available at: http://www.cdc.gov/hiv/topics/surveillance/ basic.htm#hivest. Accessed August 21, 2008.
2. National HIV/AIDS Strategy for the United States. 2010. Available at: http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf. Accessed September 27, 2011.
3. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1-17; quiz CE1-4.
4. Moyer VA. Screening for HIV: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2013;159:51-60.
5. d'Almeida KW, Kierzek G, de Truchis P, et al. Modest public health impact of nontargeted human immunodeficiency virus screening in 29 emergency departments. Arch Intern Med. 2012;172:12-20.
6. Haukoos JS. The impact of nontargeted HIV screening in emergency departments and the ongoing need for targeted strategies. Arch Intern Med. 2012;172:20-22.
7. Holtgrave DR. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing. PLoS Med. 2007;4:e194.
8. Haukoos JS, Hopkins E, Conroy AA, et al. Routine opt-out rapid HIV screening and detection of HIV infection in emergency department patients. JAMA. 2010;304:284-292.
9. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep. 2001;50:1-57; quiz CE1-19a1-CE6-a1.
10. Rothman RE, Lyons MS, Haukoos JS. Uncovering HIV infection in the emergency department: a broader perspective. Acad Emerg Med. 2007; 14:653-657.
11. Centers for Disease Control and Prevention. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR Morb Mortal Wkly Rep. 1986;35:152-155.
12. Centers for Disease Control and Prevention. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. Center for Disease Control and Prevention. MMWR Recomm Rep. 1993;42:1-6.
13. Chen Z, Branson B, Ballenger A, et al. Risk assessment to improve targeting of HIV counseling and testing services for STD clinic patients. Sex Transm Dis. 1998;25:539-543.
14. Peterman TA, Todd KA, Mupanduki I. Opportunities for targeting publicly funded human immunodeficiency virus counseling and testing. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:69-74.
15. Gerbert B, Bronstone A, McPhee S, et al. Development and testing of an HIV-risk screening instrument for use in health care settings. Am J Prev Med. 1998;15:103-113.
16. Haukoos JS, Lyons MS, Lindsell CJ, et al. Derivation and validation of the Denver Human Immunodeficiency Virus (HIV) risk score for targeted HIV screening. Am J Epidemiol. 2012;175:838-846.
17. Rosenberg ES, Delaney KP, Branson BM, et al. Re: "Derivation and validation of the Denver human immunodeficiency virus (HIV) risk score for targeted HIV screening". Am J Epidemiol. 2012;176:567-568.
18. Census Regions of the United States. Available at: http://apps.bts.gov/ publications/America-on-the-go/us-business-travel/html/figure-02.html. Accessed July 31, 2013.
19. Hsieh YH, Haukoos J, Rothman R. External validation of an abbreviated version of the Denver HIV Risk Score. Acad Emerg Med. 2011;18:S122.
20. Bartlett JG, Branson BM, Fenton K, et al. Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. JAMA. 2008;300:945-951.
21. Hutchinson AB, Farnham PG, Duffy N, et al. Return on public health investment: CDC's Expanded HIV Testing Initiative. J Acquir Immune Defic Syndr. 2012;59:281-286.
22. Kecojevic A, Lindsell CJ, Lyons MS, et al. Public health and clinical impact of increasing emergency department-based HIV testing: perspectives from the 2007 conference of the national emergency department HIV testing consortium. Ann Emerg Med. 2011;58(suppl 1):S151-S9 e1.
23. Waxman MJ, Popick RS, Merchant RC, et al. Ethical, financial, and legal considerations to implementing emergency department HIV screening: a report from the 2007 conference of the national emergency department HIV testing consortium. Ann Emerg Med. 2011;58(suppl 1): S33-S43.
24. Hsieh YH, Wilbur L, Rothman RE. HIV testing in U.S. emergency departments: at the crossroads. Acad Emerg Med. 2012;19:975-977.
25. Hoover JB, Tao G, Heffelfinger JD. Monitoring HIV testing at visits to emergency departments in the United States: very-low rate of HIV testing. J Acquir Immune Defic Syndr. 2013;62:90-94.
26. Sankoff J, Hopkins E, Sasson C, et al. Payer status, race/ethnicity, and acceptance of free routine opt-out rapid HIV screening among emergency department patients. Am J Public Health. 2012;102:877-883.
27. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States-an analysis of cost-effectiveness. N Engl J Med. 2005;352:586-595.
28. Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352:570-585.